University of Oxford's Moa Technology has received series A support to progress its vision of marketing potent herbicides discovered via its high-throughput, in-vivo screening platform.
Stanford Daper Fund-backed Boatsetter has increased its series A to at least $27.8m with $10m from investors including WestCap Group and Valor Equity Partners.
Gene therapy developer Renovacor, a Temple University spinout, has secured series A funding from investors including Novartis Venture Fund.
The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.
BlueDot, a disease containment technology spinout set up by St Michael’s Hospital and Mars Innovation, has secured series A capital.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Novo, Partners Healthcare and Sham all contributed to a $74.6m round for Alizé Pharma 3, which is exploiting research from three US institutions.
Stanford University has backed a $12m series A for identity management technology developer Truework, which has been expanding its business in the employment and loan referencing space.